Pediatric Transplant Survival Rates

The Hillman Center for Pediatric Transplantation at Children’s Hospital of Pittsburgh of UPMC has performed more pediatric transplants than any other pediatric transplant center. Our transplant survival rates consistently beat the national average and are among the world’s best.

Liver Transplant Survival Rates

Children’s Hospital of Pittsburgh of UPMC’s liver transplant survival rates consistently beat the national average and are among the world’s best. Ever since world-renowned transplant surgeon Thomas E. Starzl, MD, PhD, initiated Children’s pediatric liver transplantation program in 1981, the program has become the premier tertiary care provider for children with end-stage liver disease.

Liver Transplant Survival
1 Year  98%  national average  95% 
3 Years  93%  national average  92% 

Intestine Transplant Survival Rates

Children's Hospital of Pittsburgh of UPMC has excellent survival rates for intestinal transplantation. Patients of Children’s pediatric intestinal transplant program represent the world’s first and most successful series of small intestine transplants.

Intestine Transplant Survival
1 Year  100%  national average  90% 
3 Years  74%  national average  72% 

Heart Transplant Survival Rates

Children's Hospital is one of the most active pediatric transplant centers in the world for children in heart failure.

Heart Transplant Survival
1 Year  100%  national average  95% 
3 Years  100%  national average  88% 

Lung Transplant Survival Rates

Our transplant team performs lung transplants for children suffering from lung disease including cystic fibrosis and pulmonary hypertensionn.

Lung Transplant Survival
3 Years  100%  national average  65% 

Kidney Transplant Survival Rates

The Kidney Transplant Program at the Hillman Center for Pediatric Transplantation at Children’s Hospital of Pittsburgh of UPMC has performed hundreds of pediatric kidney transplants with survival rates that are among the best in the nation.

Kidney Transplant Survival
1 Year  100%  national average  99% 
3 Years  100%  national average  99% 

Blood and Marrow Transplant Survival Rates

Blood and Marrow Transplantation is used to treat a number of cancers, blood diseases and immune disorders that were once considered incurable. The BMT program at Children's is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT).

Blood and Bone Marrow Transplant (2008-December 2013)
Outcome Measure Type Children's Hospital
100-Day Survival1 All** 97%
One-Year Non-Relapsed Mortality2 All**
3%
One-Year Overall Survival3 All**
94%

** Includes auto-BMT, allo-related BMT, allo-unrelated and cord blood transplants.

1 Percentage of patients living 100 or more days following the transplant procedure (This takes into account deaths due to transplant- and disease-related causes.)

2 Percentage of patients who died due to causes other than related to underlying disease

3 Percentage of patients living one or more years following the transplant procedure


Sources: Internal data, Hillman Center for Pediatric Transplantation; Scientific Registry of Transplant Recipients (www.srtr.org), December 2015 release.